Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Lungs”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03583086
What this trial is testing

Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors

Who this might be right for
Thymic CarcinomaNon-small Cell Lung CancerRefractory Thoracic Tumors+1 more
Vanderbilt-Ingram Cancer Center 88
Not applicableEnded earlyNCT00912366
What this trial is testing

Assessment of Video Assisted Thoracoscopic Surgery (VATS) Versus Open Surgery for Patients Undergoing Lobectomy

Who this might be right for
Non Small Cell Lung Cancer
Medtronic - MITG 39
Testing effectiveness (Phase 2)Ended earlyNCT05325866
What this trial is testing

A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression

Who this might be right for
Solid Tumors
Amgen 260
Not applicableStudy completedNCT00899782
What this trial is testing

Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer

Who this might be right for
Lung CarcinomaLung NeoplasmMalignant Lung Neoplasm
Alliance for Clinical Trials in Oncology 500
Not applicableStudy completedNCT00263731
What this trial is testing

Metabolomic Analysis of Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell LungCarcinoma, Small Cell Lung
University of Louisville 249
Early research (Phase 1)Active Not RecruitingNCT02088645
What this trial is testing

177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer.

Who this might be right for
Thyroid Cancer, MedullaryNeuroendocrine Tumor of the Lung Grade 1 and 2Neuroendocrine Tumor of the Thymus Grade 1 and 2+1 more
University Hospital, Basel, Switzerland 24
Testing effectiveness (Phase 2)Study completedNCT01635270
What this trial is testing

Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung Carcinoma

Who this might be right for
Non-small Cell Lung CancerRadiation TherapyLocally Advanced Disease+2 more
Centre Leon Berard 54
Testing effectiveness (Phase 2)Looking for participantsNCT07603856
What this trial is testing

A Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerMetastatic Lung Cancer
University of Chicago 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT06188702
What this trial is testing

S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP

Who this might be right for
MTAP-deleted Solid Tumors
Servier Bio-Innovation LLC 60
Testing effectiveness (Phase 2)Looking for participantsNCT03808337
What this trial is testing

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Who this might be right for
Triple Negative Breast CancerNon Small Cell Lung CancerMetastatic Breast Cancer+1 more
Memorial Sloan Kettering Cancer Center 145
Testing effectiveness (Phase 2)Study completedNCT05795595
What this trial is testing

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more
CRISPR Therapeutics AG 19
Large-scale testing (Phase 3)Study completedNCT00002930
What this trial is testing

PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery

Who this might be right for
Esophageal CancerLung Cancer
Memorial Sloan Kettering Cancer Center 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT07703228
What this trial is testing

Second-Line Sacituzumab Tirumotecan Plus Anlotinib for Advanced Driver Gene-Negative Non-Squamous NSCLC

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC Stage IIIB~IVSecond-line Therapy+1 more
Nanfang Hospital, Southern Medical University 38
Not applicableNot Yet RecruitingNCT07670442
What this trial is testing

Epigenomic Profiling of Circulating Cell-Free DNA (cfDNA) to Characterize the Dynamic Evolution of Molecular Subtypes in Extensive-Stage Small Cell Lung Cancer During First-Line Chemoimmunotherapy

Who this might be right for
Small Cell Lung Cancer
Assistance Publique - Hôpitaux de Paris 50
Testing effectiveness (Phase 2)Study completedNCT03591731
What this trial is testing

Nivolumab +/- Ipilimumab in Patients With Advanced, Refractory Pulmonary or Gastroenteropancreatic Poorly Differentiated Neuroendocrine Tumors (NECs)

Who this might be right for
Neuroendocrine Carcinoma
Intergroupe Francophone de Cancerologie Thoracique 185
Not applicableLooking for participantsNCT05778253
What this trial is testing

The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCC

Who this might be right for
Lung Squamous Cell Carcinoma
Second Xiangya Hospital of Central South University 50
Early research (Phase 1)Study completedNCT01263353
What this trial is testing

Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor of the Pulmonary ot Gastroenteropancreatic System
Novartis Pharmaceuticals 36
Early research (Phase 1)WithdrawnNCT00017537
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer

Who this might be right for
Breast CancerGastric CancerLung Cancer+2 more
University of Alabama at Birmingham
Testing effectiveness (Phase 2)Active Not RecruitingNCT04607954
What this trial is testing

Durvalumab and Lurbinectedin for the Treatment of Relapsed or Refractory Small Cell Lung Cancer

Who this might be right for
Platinum-Resistant Lung Small Cell CarcinomaPlatinum-Sensitive Lung Small Cell CarcinomaRecurrent Extensive Stage Lung Small Cell Carcinoma+1 more
Mayo Clinic 29
Testing effectiveness (Phase 2)Study completedNCT00088556
What this trial is testing

Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Telik 100
Next Page